UK COVID PPE inquiry finds inadequate preparation, reveals near-£10bn PPE waste and calls for systemic reform

The latest COVID-19 inquiry M5 brief exposes that the UK was not adequately prepared for a pandemic, with inadequate stockpiles and flawed procurement. It highlights that in England only about a third of emergency stock PPE was immediately usable, while others degraded or failed to meet specifications, and notes gaps in respiratory protection across the devolved nations. The rushed response forced large purchases in a very short window, under pressure and with unusual suppliers gaining access through a controversial high-priority lane. The report signals nearly £10 billion wasted on PPE. Original Publisher: The Conversation.

• Only around a third of emergency masks in England were immediately usable
• England, Wales, Scotland lacked sufficient high-grade respiratory protection; Northern Ireland stock mainly gloves
• Rushed procurement and a high-priority lane led to favourable access for some politically connected companies
• Lessons emphasize supply chain mapping, diversification, value-based procurement, and linking stockpiles to daily NHS supply

Overview

The COVID-19 inquiry’s latest report investigates the procurement and distribution of personal protective equipment (PPE) in the UK during the pandemic, concluding that the country was not adequately prepared. It finds that pre-pandemic PPE stockpiles were inadequate and had not undergone rigorous means testing. In England, only about one third of the masks held in the emergency stockpile were immediately usable; the remainder either degraded or failed to meet COVID-19 specifications. Wales and Scotland were noted to lack sufficient high-grade respiratory protection, while Northern Ireland’s stock was largely gloves. The combination of demand surges, pressure on normal checks, and the entry of unfamiliar suppliers created a rushed procurement landscape and a controversial high priority lane that granted some politically connected firms easier access to contracts.

Procurement and market dynamics

The inquiry links the hurried response to widespread inefficiencies and mispricing, contributing to almost £10 billion being wasted on PPE that was unsuitable or overpriced. Frontline NHS and social care workers faced uncertainty as guidance shifted under supply pressures, heightening fear and risk among staff and patients. The report notes that the urgency of the period strained traditional procurement procedures and allowed untested suppliers to enter the market.

Historical context and governance

The inquiry situates these problems within a longer arc of preparedness. It points to public warnings highlighted by a 2016 Cygnus exercise that underscored pandemic risks, yet found that many weaknesses identified then remained unaddressed when the COVID-19 crisis arrived. The takeaway is not an inability to identify risks but a failure to translate warnings into concrete, actionable plans with accountable leadership.

Lessons and reforms

In March 2026 the government introduced a new pandemic preparedness strategy outlining measures to strengthen health protection, surveillance, testing, vaccines and treatments. The report stresses several actionable lessons: map critical products from manufacture to delivery, identify single points of failure such as reliance on one supplier or country, and use that intelligence to build stockpiles safely and responsibly. It also advocates testing disruption scenarios to determine which products warrant larger emergency reserves and which can be locally sourced or sourced quickly in a crisis.

Procurement philosophy and supplier resilience

Speed and price should not be the sole metrics for procurement decisions. The report argues for a broader framework that includes product quality, supplier reliability, manufacturing location, delivery times and environmental impact. Value-based procurement, which weighs supplier performance alongside cost, is recommended to improve resilience. Diversifying suppliers is essential to reduce shared points of failure and to avoid over-reliance on a single company, country or region.

Stockpile management and integration with the NHS

A resilient PPE stockpile requires visibility, timely information sharing, flexibility and the ability to respond to changing demand. The NHS and government should track what stock is available, where it is stored, when it will expire, and how quickly it is being used. Stockpiles should be linked to everyday NHS supply chains rather than treated as static warehouses. Better inventory management could curb wastage, such as the £12.5 million worth of expired PPE reported in July 2025, and prevent a recurrence of losses tied to outdated stock or misaligned demand signals.

Outlook and accountability

The inquiry frames accountability as central to reform. A named organisation or senior leader should oversee critical PPE supplies, act on early warning signals, and ensure that recommendations from inquiries and emergency exercises are implemented. The overall message is that lessons from the COVID-19 inquiry and ongoing preparedness exercises must shape future strategy to restore public confidence and ensure rapid, reliable protection for frontline workers and patients.